JB REVERSE CONVERTIBLE - DOCMORRIS Stock

SAFJJB

CH1282665525

Market Closed - Bid/Ask 11:20:00 2024-05-22 EDT			After market 11:15:00
100.5 ^CHF	-0.05%		100.6	+0.15%

1 month	-1.90%
3 months	-1.52%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DOCMORRIS AG

Chart JB REVERSE CONVERTIBLE - DOCMORRIS

Latest news about DOCMORRIS AG

Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	05-23
DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025	05-23	EQ
DOCMORRIS : Gets a Buy rating from Baader Bank	05-22	ZD
DOCMORRIS : Gets a Sell rating from UBS	05-21	ZD

More news

Quotes 5-day view

Date	Price	Change
24-05-22	100.5	-0.05%
24-05-21	100.6	-1.28%
24-05-16	101.8	-0.05%
24-05-14	101.9	-0.05%

Delayed Quote Swiss Exchange

Last update May 22, 2024 at 11:20 am

More quotes

Static data

Product type	Certificati Azionari e Obbl.ri
Buy / Sell	CALL
Underlying	DOCMORRIS AG
Issuer	Bank Julius Bär
	SAFJJB
ISIN	CH1282665525
Date issued	2023-09-05
Strike	39.98 CHF
Maturity	2024-09-05 (104 Days)
Parity	0.04 : 1
Emission price	100 CHF
Emission volume	N/A
Settlement	entrambi
Currency	CHF

Technical Indicators

Highest since issue	102.6 CHF
Lowest since issue	84.5 CHF
Spread	5 CHF
Spread %	0.50%

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

More about the company

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DocMorris AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

62.4 CHF

Average target price

99.24 CHF

Spread / Average Target

+59.04%

Consensus